Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-up.
Kollerits B, Heinrich J, Pichler M, Rantner B, Klein-Weigel P, Wölke G, Brasche S, Strube G, Kronenberg F; Erfurt Male Cohort. Kollerits B, et al. Among authors: pichler m. Atherosclerosis. 2008 May;198(1):214-22. doi: 10.1016/j.atherosclerosis.2007.09.012. Epub 2007 Oct 22. Atherosclerosis. 2008. PMID: 17950299
Beta subunit heterogeneity in neuronal L-type Ca2+ channels.
Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J. Pichler M, et al. J Biol Chem. 1997 May 23;272(21):13877-82. doi: 10.1074/jbc.272.21.13877. J Biol Chem. 1997. PMID: 9153247 Free article.
Poor adherence during adolescence is a risk factor for becoming lost-to-follow-up in patients with phenylketonuria.
Beghini M, Pichler M, Tinnefeld FC, Metz M, Möslinger D, Konstantopoulou V, Spenger J, Kautzky-Willer A, Frommlet F, Scherer T, Hufgard-Leitner M. Beghini M, et al. Among authors: pichler m. Mol Genet Metab Rep. 2024 May 9;39:101087. doi: 10.1016/j.ymgmr.2024.101087. eCollection 2024 Jun. Mol Genet Metab Rep. 2024. PMID: 38766496 Free PMC article.
Enhancing oncogenic signaling to kill cancer cells.
Noeparast M, Timofeev O, Pichler M. Noeparast M, et al. Among authors: pichler m. Trends Pharmacol Sci. 2024 May 10:S0165-6147(24)00091-9. doi: 10.1016/j.tips.2024.04.011. Online ahead of print. Trends Pharmacol Sci. 2024. PMID: 38734500 Free article.
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J; TITAN-TCC Study Group. Grimm MO, et al. Among authors: pichler m. JAMA Oncol. 2024 May 9:e240938. doi: 10.1001/jamaoncol.2024.0938. Online ahead of print. JAMA Oncol. 2024. PMID: 38722641
600 results